USA - NYSE:NEUE - US10920V4041 - Common Stock
The current stock price of NEUE is 6.753 USD. In the past month the price increased by 0.49%. In the past year, price increased by 29.87%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.32 | 291.50B | ||
| ELV | ELEVANCE HEALTH INC | 10.62 | 73.37B | ||
| HUM | HUMANA INC | 12.53 | 28.52B | ||
| CNC | CENTENE CORP | 9 | 17.87B | ||
| HQY | HEALTHEQUITY INC | 28.91 | 8.77B | ||
| MOH | MOLINA HEALTHCARE INC | 7.45 | 7.45B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 3.27B | ||
| PGNY | PROGYNY INC | 38.97 | 2.11B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.27B |
NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. The company is headquartered in Doral, Florida and currently employs 986 full-time employees. The company went IPO on 2021-06-24. The Company’s segments include NeueCare and NeueSolutions. The NeueCare segment is a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across the Affordable Care Act (ACA) Marketplace, Medicare, and Medicaid. NeueCare delivers in-person and virtual clinical care through its 66-owned primary care clinics within an integrated care delivery system. Its integrated system of care includes embedded pharmacy, laboratory, radiology, and population health focused specialty services. The company offers consumers providing primary care, behavioral health, rotating specialties, pharmacy, radiology, and laboratory services, many times at a single location. The NeueSolutions segment is a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers. NeueSolutions serves approximately 42,000 value-based care consumers.
NEUEHEALTH INC
9250 Nw 36Th Street, Suite 420
Doral FLORIDA US
Employees: 986
Phone: 16122381321
NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. The company is headquartered in Doral, Florida and currently employs 986 full-time employees. The company went IPO on 2021-06-24. The Company’s segments include NeueCare and NeueSolutions. The NeueCare segment is a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across the Affordable Care Act (ACA) Marketplace, Medicare, and Medicaid. NeueCare delivers in-person and virtual clinical care through its 66-owned primary care clinics within an integrated care delivery system. Its integrated system of care includes embedded pharmacy, laboratory, radiology, and population health focused specialty services. The company offers consumers providing primary care, behavioral health, rotating specialties, pharmacy, radiology, and laboratory services, many times at a single location. The NeueSolutions segment is a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers. NeueSolutions serves approximately 42,000 value-based care consumers.
The current stock price of NEUE is 6.753 USD. The price increased by 1.24% in the last trading session.
NEUE does not pay a dividend.
NEUE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
NEUEHEALTH INC (NEUE) has a market capitalization of 60.91M USD. This makes NEUE a Micro Cap stock.
You can find the ownership structure of NEUEHEALTH INC (NEUE) on the Ownership tab.
ChartMill assigns a technical rating of 4 / 10 to NEUE. When comparing the yearly performance of all stocks, NEUE is one of the better performing stocks in the market, outperforming 78.48% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to NEUE. Both the profitability and financial health of NEUE have multiple concerns.
Over the last trailing twelve months NEUE reported a non-GAAP Earnings per Share(EPS) of -6.16. The EPS decreased by -87.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.13% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed NEUE and the average price target is 7.14 USD. This implies a price increase of 5.73% is expected in the next year compared to the current price of 6.753.
For the next year, analysts expect an EPS growth of 14% and a revenue growth 28.84% for NEUE